Physician

Mariel Gonzalez-Mendoza, MD

According to 2025 Medicare claims, Mariel Gonzalez-Mendoza, MD (NPI: 1194836825) practices family practice in the Wildwood-The Villages, FL market, with the plurality of this provider's patient population coming from Sumter, FL. This provider's primary affiliated billing organization is FLORIDA MEDICAL ASSOCIATES LLC (NPI: 1336153709; TIN: 204374088) and primary practice location at 34785-3605. Gonzalez-Mendoza is affiliated with the Physician Partners ACO Reach, LLC (ACO ID: D0267), participating under the REACH model.

Gonzalez-Mendoza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 69 traditional Medicare patients, billed 182 HCPCS/CPT codes, and received $10,948 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 2,602 prescription claims across 426 beneficiaries totaling $270,614 in drug costs, led by Jardiance (Empagliflozin). 2023 DME data shows 15 claims. Open Payments data shows 1 records totaling $20. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $172,636 to $10,948. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $279,510 and ending at $270,614. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,904 to $1,932.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	517	6,879	$172,636
2016	413	5,276	$108,017
2017	44	399	$11,995
2018	49	242	$8,130
2019	25	68	$3,040
2020	136	367	$23,146
2021	203	589	$42,859
2022	96	416	$34,155
2023	122	600	$44,152
2024	69	182	$10,948

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	556	4,444	$279,510
2016	578	5,484	$337,184
2017	497	4,616	$245,744
2018	441	4,916	$260,650
2019	406	2,843	$155,139
2020	255	872	$52,942
2021	467	4,467	$320,819
2022	362	2,157	$185,908
2023	307	2,512	$292,337
2024	426	2,602	$270,614

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	29	$2,625
2016	11	40	$459
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	15	$2,822
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	11	11	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	54	84	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	36	40	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	24	1,740	$33,750
Eliquis	Apixaban	12	900	$17,225
Gabapentin	Gabapentin	83	6,360	$2,137
Levothyroxine Sodium	Levothyroxine Sodium	135	11,566	$1,648
Atorvastatin Calcium	Atorvastatin Calcium	148	12,707	$1,622

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$20	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mariel Gonzalez-Mendoza, MD?

Tedicare shows public-source Medicare data for Mariel Gonzalez-Mendoza, MD (NPI 1194836825), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mariel Gonzalez-Mendoza, MD have ACO affiliation data?

Mariel Gonzalez-Mendoza, MD is shown with ACO affiliation data for Physician Partners ACO Reach, LLC (REACH, ACO ID D0267).

What billing organization is linked to Mariel Gonzalez-Mendoza, MD?

Mariel Gonzalez-Mendoza, MD is linked to FLORIDA MEDICAL ASSOCIATES LLC (billing NPI 1336153709) in the available physician profile data.

Does Mariel Gonzalez-Mendoza, MD have Open Payments data?

Mariel Gonzalez-Mendoza, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.